| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | bimatoprost (Bimi®) |
| Formulation | 0.3 mg/ml eye drops |
| Reference number | 5238 |
| Indication | Reduction of intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as mono-therapy or as adjunctive to beta blockers) |
| Company | Scope Ophthalmics Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 09/11/2022 |